Guochuang Center: Domestic high -performance medical device "Star Chaser"

The "small earplugs" of the stroke of the brain -stroke in advance can monitor the contact lenses of the eye pressure in real time, so that Shenzhen doctors participate in the long -range ultrasonic robot participating in the Tibetan consultation ... On July 27, the first "Guochuang Cup" medical device innovation and entrepreneurial competition contest The Finals of the China Medical Equipment Innovation Contest was held in Longhua District, Shenzhen, and 20 projects from all over the country competed.

△ Participate in the guests

It is reported that the theme of this competition is "innovative leadership, combination of production and finance", and aims to discover outstanding teams and high -quality projects in the frontier fields of medical equipment, promote the breakthrough of the industry's core technology, accelerate the transformation of scientific and technological achievements, and provide the "Healthy China" strategy. Key guarantee.

The competition is sponsored by the National High -performance Medical Devices Institute Innovation Center (hereinafter referred to as the "National Innovation Center"). , Jointly organized by the Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences, Mai Rui Medical, Lianying Medical, Xianjian Technology, and Harbin Institute of Technology.

Innovate the micro -light, gather the industrial stars

If head companies represented by Mai Rui Medical and Lianying Medical, are the "lighthouses" of domestic high -performance medical devices, and now more entrepreneurs join this field. "Xinghe".

The first "Guochuang Cup" contest provides the platform for these "Stars of Tomorrow".

It is reported that the total bonus of the competition was 3.01 million, of which the first prize of the first primary group was 300,000, and the first prize of the enterprise group was 500,000. Since its official launch in October 2021, the contest has attracted more than 300 projects to register. After the preliminary and semi -final competition, and the on -site selection of the review experts, 8 first -found group projects and 12 enterprise group projects were finally born to participate in the final competition.

The reporter learned at the scene that many outstanding domestic innovation technologies have emerged in this competition.

For example, the "IRTA Digital Tumor Precision Rulonging Treatment System" of the Chuangchuang Group organically combines electrical pulse tumor ablation technology, endoscopic technology, and interventional technology. It provides more minimally invasive and safe treatment methods for early cancer and mucosal lesions of digestive tract to reduce Tumor ablation technology threshold.

△ Ren Feng Gang, founder of Pulse Medical Medical

Feng Gang, the person in charge of the project and the founder of the pulse condensate, told reporters that he was a surgeon at the First Affiliated Hospital of Xi'an Jiaotong University. The research and development of this time was guided by clinical needs. "How to make cancer and other lesions was discovered early, it was the common wish of the medical community," Ren Feng Gang said.

Break into the "unmanned area" and break through key technologies

In this project roadshow, "domestic replacement" became a high -frequency vocabulary mentioned by the participants. Han Lubing, CTO of pulse condensation, told reporters that mastering key core technologies and developing independent intellectual property equipment is the direction of domestic medical device practitioners.

In addition to mastering key technologies, there are many projects to break through the "unmanned area".

As one of the participating projects of the enterprise, the "3D printing new bionic artificial bone and implant product" is one of the representatives. Different from the traditional 3D printing materials, the team innovatively adopts pores of metal materials for related development. "As a bone implant material, it has a significant advantage in many aspects such as organizational function reconstruction, but the technical barriers are large, and our team dares to launch this 'hard bone'." Essence

Yang Jinghao said that the core member of the team returned to China after graduating from Harvard Medical College, and eventually settled the company in Shenzhen. "There are some bold ideas in the field of scientific research. Only the soil provided in Shenzhen can take root. This time, I participated in the competition and saw so many excellent teams gathered in Shenzhen, and I felt that we were right." He said.

Supporting the development of medical devices and biomedical industries, Shenzhen has spared no effort. In June of this year, the "Shenzhen Municipal People's Government on the Development and Greeting Strategic Emerging Industry Cluster and Cultivating Development of Future Industry" proposed that the high -end medical device industry cluster is one of the focus of development. The "Opinions" stated that it is necessary to develop subdivisions such as new medical imaging, life monitoring and life support, high -end interventional products, etc., break through high -end imaging systems, surgical robots, new in vitro diagnostic equipment, high -throughput gene sequencers and other major equipment and key Parts and components give full play to the role of national high -performance medical device innovation centers, support Nanshan, Longhua, Pingshan, Guangming and other districts to build gathering areas, and promote the high -quality development of the high -end medical device industry.

Build a vertical ecosystem and find the country for the country

Domestic high -end medical devices are dazzling, and the National Innovation Center is the "star chaser."

In April 2020, the Ministry of Industry and Information Technology approved and agreed, and the National Innovation Center officially established and settled in Longhua District, Shenzhen. As the first national manufacturing innovation center in Shenzhen, it is also the only innovation center established by the country in the field of medical device. It aims to provide a solid guarantee for the establishment of a medical device country in my country and to finally achieve the goal of "Healthy China 2030".

"The vertical innovation ecosystem in the field of medical device." Liu Heng, deputy general manager of the National Innovation Center, described the transcript handed in the center for more than two years.

In this system, the lowest level is the original innovation support provided by the research institute as the cornerstone to support the center of innovation input; since then it is the central led medical device CRO and CDMO public service platform. Clinical trials, registered regulations, customized production and other technical services; in addition, in order to become the "cradle" of the heavy weapon castor of more countries, the National Innovation Center has established a professional incubator to provide the startups with venues, facilities, information and other services; for the starting company; for the startup; Accelerate the productization and industrialization of technological achievements, and the center has established industrial funds to provide capital assistance for enterprise growth. "'Guochuang Cup' is an important platform for our promoting industry collision and promoting integration and innovation," Liu Heng said. "At present, many projects have cooperated with the Guochuang Center and shareholders. We hope to build the competition as the most influential medical device professional event in the country. "

△ The founder of Anjieming Qin Zhen

As one of the "glaucoma diagnostic equipment", which is one of the participating projects in the enterprise group, it has received a lot of attention with technologies such as "measuring eye pressure contact lenses". As a project R & D, Shenzhen Anjieming Medical Technology Co., Ltd. is one of the enterprises incubated by Guochuang Center. Qin Zhen, the founder of Anjieming, told reporters that the center provided a series of help for enterprises with a series of help such as rent reduction, resource docking, technical support, and financing services.

△ Luo Fei, the founding partner of Songhe Capital

△ Tao Feng, founding partner of Boyuan Capital

As a guest at the contest, Tao Feng, the founding partner of Boyuan Capital, told reporters that "'Guochuang Cup' chose Shenzhen as the place of the competition to release the potential of this medical device innovation." Luo Fei, the founding partner of Songhe Capital, said "In the context of policy booster, clinical demand continues to emerge, and high -end manufacturing industry, the development of the medical device industry is now justified."

- END -